Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles.

Jimbow, Kowichi; Ishii-Osai, Yasue; Ito, Shosuke; Tamura, Yasuaki; Ito, Akira; Yoneta, Akihiro; Kamiya, Takafumi; Yamashita, Toshiharu; Honda, Hiroyuki; Wakamatsu, Kazumasa; Murase, Katsutoshi; Nohara, Satoshi; Nakayama, Eiichi; Hasegawa, Takeo; Yamamoto, Itsuo; Kobayashi, Takeshi

Jimbow, Kowichi; Ishii-Osai, Yasue; Ito, Shosuke; Tamura, Yasuaki; Ito, Akira; Yoneta, Akihiro; Kamiya, Takafumi; Yamashita, Toshiharu; Honda, Hiroyuki; Wakamatsu, Kazumasa; Murase, Katsutoshi; Nohara, Satoshi; Nakayama, Eiichi; Hasegawa, Takeo; Yamamoto, Itsuo; Kobayashi, Takeshi.

Afiliação

Jimbow K; Institute of Dermatology & Cutaneous Sciences, 1-27 Odori West 17, Chuo-ku, Sapporo 060-0042, Japan ; Department of Dermatology, School of Medicine, Sapporo Medical University, South 1 West 16, Chuo-ku, Sapporo 060-8556, Japan.

J Skin Cancer ; 2013: 742925, 2013.

Article em En | MEDLINE | ID: mdl-23533767

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2013 Tipo de documento: Article